Drugs / FANG(30)
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00749645 Comparator | Oct 2006 → Jan 2008 | rheumatoid arthritis | Juan C. Bertoglio, MD | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FANG(30) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00749645 ↗ |
| Route | Oral | “Andrographolide formula Oral tablets, 30mg, three times per day, during a total of 105 continuous days.” NCT00749645 ↗ |